Endogenous Creatinine Assay Kit can measure creatinine levels in urine, serum, and culture media samples. This test is done to see how well your kidneys are working. Creatinine can also be measured with a urine test. A measurement of the serum creatinine level is often used to evaluate kidney function.
This report contains market size and forecasts of Endogenous Creatinine Assay Kits in global, including the following market information:
Global Endogenous Creatinine Assay Kits Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Endogenous Creatinine Assay Kits Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Endogenous Creatinine Assay Kits companies in 2021 (%)
The global Endogenous Creatinine Assay Kits market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Jaffe's Kinetic Method Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Endogenous Creatinine Assay Kits include Roche, Siemens Healthineers, Abbott, Leadman Biochemis, Kanto Chemica, Chondrex, Beijing Leadman Biochemistry, Maccura Biotechnology and Shenzhen Goldsite Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Endogenous Creatinine Assay Kits manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Endogenous Creatinine Assay Kits Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Endogenous Creatinine Assay Kits Market Segment Percentages, by Type, 2021 (%)
Jaffe's Kinetic Method
Enzymatic Method
Global Endogenous Creatinine Assay Kits Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Endogenous Creatinine Assay Kits Market Segment Percentages, by Application, 2021 (%)
Hospital
Laboratories
Global Endogenous Creatinine Assay Kits Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Endogenous Creatinine Assay Kits Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Endogenous Creatinine Assay Kits revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Endogenous Creatinine Assay Kits revenues share in global market, 2021 (%)
Key companies Endogenous Creatinine Assay Kits sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Endogenous Creatinine Assay Kits sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Siemens Healthineers
Abbott
Leadman Biochemis
Kanto Chemica
Chondrex
Beijing Leadman Biochemistry
Maccura Biotechnology
Shenzhen Goldsite Diagnostics
Beijing Solarbio Science & Technology
Beijing Strong Biotechnologies
Ningbo Ruiyuan Biotechnology
Shanghai Fosun Pharmaceutical